DelveInsight’s “Diabetic foot ulcers Market Insights, Epidemiology, and Market Forecast -2030“ report delivers an in-depth understanding of the Diabetic foot ulcers, historical and forecasted epidemiology as well as the Diabetic foot ulcers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Facts of the Diabetic foot ulcers Market:
Request for free Sample Report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Scope of the Diabetic foot ulcers Report:
“Over 55 million Europeans suffer from diabetes, and 8 million of these patients are at risk of developing a diabetic foot ulcer.”
Diabetic foot ulcers is a lesion of all layers of skin, necrosis, or gangrene that occurs in the sole of the feet in diabetes mellitus (DM) patients, caused by: (1) causative factor (peripheral neuropathy, high foot plantar pressure, and trauma); (2) contributive factors (atherosclerosis and diabetes). Diabetic foot ulcers can be followed by bacterial invasion resulting in infection and decay, can occur in any part of the body especially in the distal part of the lower leg. The sign and symptoms of Diabetic foot ulcers (DFU) includes, swelling, discoloration, and warmth around the wound, foul-smelling discharge seeping from the wound, Pain and firmness when the wound is touched and Call used or thickened skin surrounding the ulcer.
According to Edmon, the diabetic foot ulcers are divided into two groups, namely: Neuropathic ulcers (feet is warm, perfusion is still good with pulsation still palpable, perspiration is reduced, skin dry and cracked).
Neuroischemic ulcers (feet is colder, not palpable pulsation, thin skin, smooth, and without hair, subcutaneous tissue atrophy, intermittent claudication, and rest pain may not be present due to neuropathy).
Some of the Diabetic foot ulcers Companies:
Diabetic foot ulcers Drugs Covered:
Table of Contents:
1. Report Introduction
2. Diabetic Foot Ulcers Market Overview at a Glance
3. Diabetic Foot Ulcers Disease Background and Overview
4. Diabetic Foot Ulcers Epidemiology and Patient Population
5. Diabetic Foot Ulcers Country- Wise Epidemiology
5.1. United States
5.2. EU-5
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. Spain
5.2.5. United Kingdom
5.3. Japan
6. Diabetic Foot Ulcers Treatment & Medical Practices
7. Diabetic Foot Ulcers Marketed Drugs
7.1. Regranex Gel (becaplermin): Smith & Nephew
8. Diabetic Foot Ulcers Emerging Therapies
8.1. Key Cross Competition
8.2. Plasma-generated nitric oxide: Originww
8.3. MBN-101: Microbion Corporation
9. Diabetic Foot Ulcers Market Size
10. 7MM Diabetic Foot Ulcers Country-Wise Market Analysis
10.1. United States
10.2. Germany
10.3. France
10.4. Italy
10.5. Spain
10.6. United Kingdom
10.7. Japan
11. Diabetic Foot Ulcers Report Methodology
12. DelveInsight Capabilities
13. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market